Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
Gondran C, Dumas PY, Bérard E, Bidet A, Delabesse E, Tavitian S, Leguay T, Huguet F, Borel C, Forcade E, Vergez F, Vial JP, Rieu JB, Lechevalier N, Luquet I, Canali A, Klein E, Sarry A, de Grande AC, Pigneux A, Récher C, Largeaud L, Bertoli S.
Gondran C, et al. Among authors: klein e.
Blood Cancer J. 2024 May 31;14(1):91. doi: 10.1038/s41408-024-01069-9.
Blood Cancer J. 2024.
PMID: 38821940
Free PMC article.